Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.

Data were gathered using chart review tools and a structured questionnaire ... to either engage in or abstain from behaviours that increase their risk of HIV/AIDS, such as drug use and unprotected ...

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

As the nation's AIDS walk marks its 40th year in Los Angeles, organizers say medical advances have taken lowered visibility ...

The increased prevalence of substance use disorder among people living with HIV during the COVID-19 pandemic may be attributable ... was used to evaluate substance use among participants. For each ...

Data were sourced from 19 observational cohorts and more than 30,000 people with HIV in Europe and Australia. Adults on dual or triple combination antiretroviral therapy who had CD4, HIV RNA, and at ...

Faster access to HIV drug lenacapavir in India hinges on the waiver of local clinical trials. Six companies, including three from India, have non-exclusive, royalty-free licenses to produce generic ...

Indian pharmaceutical companies are set to produce generic versions of lenacapavir, an HIV prevention drug, under agreements with US-based Gilead Sciences to distribute it in 120 resource-limited ...

AntiRetroviral Therapy and Markers of Aging [CARMA] and British Columbia CARMA-CHIWOS Collaboration [BCC3] studies) to determine whether women with HIV have higher lifetime frequencies of ...

Researchers analyzed cross-sectional data from 2 prospective cohort studies (the Children and Women: AntiRetroviral Therapy and Markers of Aging [CARMA] and British Columbia CARMA-CHIWOS Collaboration ...

The increased prevalence of substance use disorder among people living with HIV during the COVID-19 pandemic ... use among participants. For each drug reported, a Single Substance Involvement ...

On Wednesday, Gilead Sciences, a US-based pharmaceutical company, issued royalty-free licenses to 6 generic drug ... antiretroviral therapy due to issues like resistance, intolerance, or safety ...